关注
Ana Catarina Pinto
Ana Catarina Pinto
Bluepharma Indústria Farmacêutica S.A
在 bluepharmagroup.com 的电子邮件经过验证
标题
引用次数
引用次数
年份
Combination chemotherapy in cancer: principles, evaluation and drug delivery strategies
AC Pinto, JN Moreira, S Simões
Current Cancer Treatment-Novel Beyond Conventional Approaches, 2011
852011
Artificial neural networks applied to quality-by-design: From formulation development to clinical outcome
MF Simões, G Silva, AC Pinto, M Fonseca, NE Silva, RMA Pinto, ...
European Journal of Pharmaceutics and Biopharmaceutics 152, 282-295, 2020
632020
Liposomal imatinib–mitoxantrone combination: Formulation development and therapeutic evaluation in an animal model of prostate cancer
AC Pinto, JN Moreira, S Simões
The Prostate 71 (1), 81-90, 2011
452011
Ciprofloxacin sensitizes hormone-refractory prostate cancer cell lines to doxorubicin and docetaxel treatment on a schedule-dependent manner
AC Pinto, JN Moreira, S Simões
Cancer chemotherapy and Pharmacology 64, 445-454, 2009
352009
Schedule treatment design and quantitative in vitro evaluation of chemotherapeutic combinations for metastatic prostate cancer therapy
AC Pinto, S Ângelo, JN Moreira, S Simões
Cancer chemotherapy and pharmacology 67, 275-284, 2011
252011
Oromucosal products–Market landscape and innovative technologies: A review
F Bastos, AC Pinto, A Nunes, S Simoes
Journal of Controlled Release 348, 305-320, 2022
132022
Development, characterization and in vitro evaluation of single or co-loaded imatinib mesylate liposomal formulations
AC Pinto, S Angelo, JN Moreira, S Simoes
Journal of nanoscience and nanotechnology 12 (3), 2891-2900, 2012
72012
Quimioterapia combinada no tratamento do cancro: princípios e estratégias nanotecnológicas de entrega de fármacos
AC Pinto, JN Moreira, S Simões
Imprensa da Universidade de Coimbra, 2015
2015
Development of liposomal chemotherapeutic formulations for prostate cancer therapy: combination of conventional chemotherapy and a novel generation of anticancer drugs
ACS Pinto
Development of liposomal chemotherapeutic formulations for prostate cancer …, 2010
2010
In vitro evaluation of combined effects of conventional and new cytotoxic agents against a hormone-refractory prostate cancer (HRPC) cell line
AC Pinto, JN Moreira, S Simoes
BJU INTERNATIONAL 100, 35-36, 2007
2007
系统目前无法执行此操作,请稍后再试。
文章 1–10